PWMG
CTNM

Private Wealth Management Group’s Contineum Therapeutics CTNM Stock Holding History

Private Wealth Management Group’s Portfolio CTNM Stock Details CTNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-43
Closed -$301 – 1615
2025
Q1 		$301 Buy
+43
New +$391 ﹤0.01% 1436

Other funds holding CTNM

JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
RTM
Red Tree Management Redwood City, California $147M AUM 202.18% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Private Wealth Management Group's CTNM Position: Q2 2025 in Review

Private Wealth Management Group sold out of Contineum Therapeutics (CTNM) in Q2 2025, closing a stake of 43 shares — an estimated $301 sold.

Private Wealth Management Group first reported a position in CTNM in Q1 2025 and held it in 1 quarter. The position peaked at $301 in Q1 2025. 70 funds tracked by Wall St. Rank hold CTNM as of Q2 2025.

  • Private Wealth Management Group reported no remaining Contineum Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Private Wealth Management Group sold 43 Contineum Therapeutics shares in Q2 2025, an estimated $301.
  • Private Wealth Management Group first reported a position in Contineum Therapeutics in Q1 2025 and held it in 1 quarter.
  • Private Wealth Management Group's Contineum Therapeutics position peaked at $301 in Q1 2025.
  • 70 funds tracked by Wall St. Rank held Contineum Therapeutics as of Q2 2025.

Based on Private Wealth Management Group's 13F filing for Q2 2025, filed 29 Jul 2025.